Anthropometric measures and HbA1c to detect dysglycemia in young Asian women planning conception: The S-PRESTO cohort
Year: 2020
Type: article
Study design: Observational Study
Abstract: We investigated whether adding anthropometric measures to HbA1c would have stronger discriminative ability over HbA1c alone in detecting dysglycemia (diabetes and prediabetes) among Asian women trying to conceive. Among 971 Singaporean women, multiple regression models and area under receiver-operating characteristic (AUROC) curves were used to analyze associations of anthropometric (weight, height, waist/hip circumferences, 4-site skinfold thicknesses) and HbA1c z-scores with dysglycemia (fasting glucose ≥6.1 mmol/L with 2-hour glucose ≥7.8 mmol/l). The prevalence of dysglycemia was 10.9%. After adjusting for sociodemographic/medical history, BMI (Odds Ratio [OR] = 1.62 [95%CI 1.32–1.99]), waist-to-height ratio (OR = 1.74 [1.39–2.17]) and total skinfolds (OR = 2.02 [1.60–2.55]) showed the strongest associations with dysglycemia but none outperformed HbA1c (OR = 4.09 [2.81–5.94]). After adjustment for history, adding BMI, waist-to-height ratio and total skinfolds (anthropometry trio) as continuous variables to HbA1c (AUROC = 0.80 [95%CI 0.75–0.85]) performed similarly to HbA1c alone (AUROC = 0.79 [0.74–0.84]). However, using clinically-defined thresholds without considering history, as in common clinical practice, BMI ≥ 23 kg/m 2 + HbA1c ≥ 5.7% (AUROC = 0.70 [0.64–0.75]) and anthropometry trio + HbA1c ≥ 5.7% (AUROC = 0.71 [0.65–0.76]) both outperformed HbA1c ≥ 5.7% alone (AUROC = 0.61 [0.57–0.65]). In a two-stage strategy, incorporating BMI ≥ 23 kg/m 2 alongside HbA1c ≥ 5.7% into first-stage screening to identify high risk women for subsequent oral glucose tolerance testing improves dysglycemia detection in Asian women preconception.
Source: Scientific Reports
Authors: Anne H. Y. Chu, Izzuddin M. Aris, Sharon Ng, See Ling Loy, Jonathan Y Bernard, Mya Thway Tint, Wen Lun Yuan, Keith M. Godfrey, Jerry Kok Yen Chan, Lynette Pei-Chi Shek, Yap Seng Chong, Kok Hian Tan, Seng Bin Ang, Heng Hao Tan, Bernard S. M. Chern, Fabian Yap, Yung Seng Lee, Ngee Lek, Melvin Khee-Shing Leow, Chin Meng Khoo, Shiao-Yng Chan
Institutions: Agency for Science, Technology and Research, Singapore Institute for Clinical Sciences, Harvard University, National University of Singapore, Harvard Pilgrim Health Care, KK Women's and Children's Hospital, Duke-NUS Medical School, Inserm, University Hospital Southampton NHS Foundation Trust, NIHR Southampton Biomedical Research Centre, MRC Lifecourse Epidemiology Unit, University of Southampton, Nanyang Technological University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,870
Funders: National Institute for Health and Care Research, British Heart Foundation, National Research Foundation, Singapore Institute for Clinical Sciences, National Research Foundation Singapore, National University Health System, Medical Research Council, National Medical Research Council, Precursory Research for Embryonic Science and Technology
OpenAlex ID: W3033130109
